A controlled study with 314 confirmed symptomatic cases of COVID-19 reported that patients with eosinophilia had lower levels of CRP, milder clinical courses, and better disease outcomes than those without eosinophilia [41]. This evidence concerns the gene CRP and Increased total eosinophil count.